Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

著者: Paolo Lanzetta, Jean‐François Korobelnik, Jeffrey S. Heier, Sérgio Leal, Frank G. Holz, W. Lloyd Clark, David Eichenbaum, Tomohiro Iida, Xiaodong Sun, Alyson J. Berliner, Andrea Schulze, Thomas Schmelter, Ursula Schmidt-Ott, Xin Zhang, Robert Vitti, Karen Chu, Kimberly Reed, Rohini Rao, Rafia Bhore, Yenchieh Cheng, Wei Sun, Boaz Hirshberg, George D. Yancopoulos, Tien Yin Wong - The Lancet 2024 被引用: 219